← Leaderboards
Lorraine Iacovitti
Thomas Jefferson University
$10,800,609
Attributed
$13,062,242
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$13,062,242 · 10
By mechanism
R01$12,300,742 · 7
R21$431,500 · 1
R03$330,000 · 2
Top collaborators
- Alexander M Mazo5 shared
- Yuri Sykulev5 shared
- Ya-Ming Hou4 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Yuri Sykulev$9,058,653
- Ya-Ming Hou$21,661,043
- Alexander M Mazo$10,970,170
- Matthew J During$5,721,751
- Michael Lawler$94,446
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsDopamineCellsCell TypeTranscription FactorDopaminergic NeuronIn VivoStem CellsTissue /Cell CulturePhenotypeCell LineAffectInduced Pluripotent Stem CellEpigenetic ProcessTyrosine 3 MonooxygenaseHuman Embryonic Stem CellInsightDisease /Disorder ModelNerve Stem CellCell ModelProgenitorParkinson'S DiseaseParkinson DiseaseMidbrain Structure
Grant awards (41)
A cell model of YARS2-associated childhood-onset mitochondrial disease$84,144
R03 · FY2024 · HD
A cell model of YARS2-associated childhood-onset mitochondrial disease$89,856
R03 · FY2023 · HD
The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation$653,648
R01 · FY2021 · AI
Using human IPS cells to study fate, function and neurodegenerative disease$378,225
R01 · FY2021 · NS · contact PI
The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation$653,648
R01 · FY2020 · AI
Using human IPS cells to study fate, function and neurodegenerative disease$422,918
R01 · FY2020 · NS · contact PI
The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation$653,648
R01 · FY2019 · AI
Using human IPS cells to study fate, function and neurodegenerative disease$422,918
R01 · FY2019 · NS · contact PI
A patient-derived CMT cell model$78,000
R03 · FY2019 · NS
The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation$653,648
R01 · FY2018 · AI
Using human IPS cells to study fate, function and neurodegenerative disease$422,921
R01 · FY2018 · NS · contact PI
A patient-derived CMT cell model$78,000
R03 · FY2018 · NS
The Role of the De-condensed Structure of Nascent Chromatin During T Cell Differentiation$530,358
R01 · FY2017 · AI
Using human IPS cells to study fate, function and neurodegenerative disease$378,827
R01 · FY2017 · NS · contact PI
Using reporter human iPS cells to study fate, function and Parkinson's disease$345,359
R01 · FY2016 · NS · contact PI
Using reporter human iPS cells to study fate, function and Parkinson's disease$345,359
R01 · FY2015 · NS · contact PI
Using reporter human iPS cells to study fate, function and Parkinson's disease$341,904
R01 · FY2014 · NS · contact PI
Using reporter human iPS cells to study fate, function and Parkinson's disease$333,270
R01 · FY2013 · NS · contact PI
Using reporter human iPS cells to study fate, function and Parkinson's disease$380,141
R01 · FY2012 · NS · contact PI
Studies of Purified Dopamine Neurons$307,851
R01 · FY2007 · NS · contact PI
Imaging stem cell implants in neurodegenerative disease$268,841
R01 · FY2007 · NS · contact PI
Using Stem Cells in Animal Models of Parkinson's Disease$324,252
R01 · FY2006 · NS · contact PI
Studies of Purified Dopamine Neurons$317,045
R01 · FY2006 · NS · contact PI
Imaging stem cell implants in neurodegenerative disease$277,318
R01 · FY2006 · NS · contact PI
Using Stem Cells in Animal Models of Parkinson's Disease$332,055
R01 · FY2005 · NS
Studies of Purified Dopamine Neurons$324,675
R01 · FY2005 · NS
Using Stem Cells in Animal Models of Parkinson's Disease$332,055
R01 · FY2004 · NS
Studies of Purified Dopamine Neurons$324,675
R01 · FY2004 · NS
Neural Stem Cells Grafts in Primate Models of Parkinsons$39,000
R21 · FY2004 · NS
Using Stem Cells in Animal Models of Parkinson's Disease$332,055
R01 · FY2003 · NS
Neural Stem Cells Grafts in Primate Models of Parkinsons$196,250
R21 · FY2003 · NS
Using Stem Cells in Animal Models of Parkinson's Disease$324,182
R01 · FY2002 · NS
FACTORS REGULATING TYROSINE HYDROXYLASE GENE EXPRESSION$300,962
R01 · FY2002 · NS
STUDIES OF PURIFIED DOPAMINE NEURONS$269,403
R01 · FY2002 · NS
Neural Stem Cells Grafts in Primate Models of Parkinsons$196,250
R21 · FY2002 · NS
FACTORS REGULATING TYROSINE HYDROXYLASE GENE EXPRESSION$292,197
R01 · FY2001 · NS
STUDIES OF PURIFIED DOPAMINE NEURONS$261,557
R01 · FY2001 · NS
FACTORS REGULATING TYROSINE HYDROXYLASE GENE EXPRESSION$50,000
R01 · FY2001 · NS
FACTORS REGULATING TYROSINE HYDROXYLASE GENE EXPRESSION$292,856
R01 · FY2000 · NS
STUDIES OF PURIFIED DOPAMINE NEURONS$253,937
R01 · FY2000 · NS
MELATONIN EFFECTS ON DAMAGED DOPAMINE NEURONS$198,034
R01 · FY2000 · NS